These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37459332)

  • 41. [Changes in genotype prevalence of human papillomavirus over 10-year follow-up of a cervical cancer screening cohort].
    Dong L; Hu SY; Zhang Q; Feng RM; Zhang L; Zhao XL; Ma JF; Shi SD; Zhang X; Pan QJ; Zhang WH; Qiao YL; Zhao FH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jan; 38(1):20-25. PubMed ID: 28100371
    [No Abstract]   [Full Text] [Related]  

  • 42. Prevalence of human papillomavirus genotypes in women with normal and abnormal cervical cytology in Iran.
    Ghaffari SR; Sabokbar T; Mollahajian H; Dastan J; Ramezanzadeh F; Ensani F; Yarandi F; Mousavi-Jarrahi A; Mohagheghi MA; Moradi A
    Asian Pac J Cancer Prev; 2006; 7(4):529-32. PubMed ID: 17250423
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: the CLEOPATRE study.
    Castellsagué X; Iftner T; Roura E; Vidart JA; Kjaer SK; Bosch FX; Muñoz N; Palacios S; San Martin Rodriguez M; Serradell L; Torcel-Pagnon L; Cortes J;
    J Med Virol; 2012 Jun; 84(6):947-56. PubMed ID: 22499018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong's largest independent pathology laboratory.
    Jiang L; Tian X; Peng D; Zhang L; Xie F; Bi C; Wang R; Wang J; Qi D
    PLoS One; 2019; 14(1):e0210311. PubMed ID: 30653566
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genotype distribution of cervical HPV among Caribbean women in a population-based study in Martinique: The DEPIPAPUFR study.
    Najioullah F; Dorival MJ; Joachim C; Dispagne C; Macni J; Abel S; Sulpicy C; Charpentier-Baltide H; Sainte-Rose D; Salomon-Frechou B; Dieye M; Véronique-Baudin J; Pré M; Marquet M; Wan-Ajouhu G; Janky E; Riethmuller D; Cesaire R;
    PLoS One; 2021; 16(10):e0257915. PubMed ID: 34618835
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence and human papillomavirus (HPV) genotype distribution in Suzhou, China.
    Wang T; Luan L; Deng J; Liu N; Wu Q; Gong T; Zhu J; Zhang Z; Zhang J
    Hum Vaccin Immunother; 2023 Aug; 19(2):2241309. PubMed ID: 37519009
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009-2019.
    Liu Y; Ang Q; Wu H; Xu J; Chen D; Zhao H; Liu H; Guo X; Gu Y; Qiu H
    Virol J; 2020 Jul; 17(1):104. PubMed ID: 32660490
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human papillomavirus prevalence and vaccine effectiveness in young women in Germany, 2017/2018: results from a nationwide study.
    Loenenbach A; Schönfeld V; Takla A; Wiese-Posselt M; Marquis A; Thies S; Sand M; Kaufmann AM; Wichmann O; Harder T
    Front Public Health; 2023; 11():1204101. PubMed ID: 37719724
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HPV genotype prevalence in Indian women with cervical disease and estimation of the potential impact of HPV vaccines on prevention of cervical cancer.
    Nagaraja M; Narendra H; Venkataramana B; Kalawat U
    Indian J Med Microbiol; 2023; 43():73-78. PubMed ID: 36241529
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidemiology and genotypes analysis of human papillomavirus infection in Beijing, China.
    Wang J; Li H; Zhang J; Wang H; Li Y; Liu Z; Liu H
    Virol J; 2024 Jan; 21(1):19. PubMed ID: 38229145
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human papillomavirus genotype distribution and socio-behavioural characteristics in women with cervical pre-cancer and cancer at the start of a human papillomavirus vaccination programme: the CIN3+ plus study.
    Egli-Gany D; Spaar Zographos A; Diebold J; Masserey Spicher V; Frey Tirri B; Heusser R; Dillner J; Petignat P; Sahli R; Low N;
    BMC Cancer; 2019 Jan; 19(1):111. PubMed ID: 30700274
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions.
    Paz-Zulueta M; Álvarez-Paredes L; Rodríguez Díaz JC; Parás-Bravo P; Andrada Becerra ME; Rodríguez Ingelmo JM; Ruiz García MM; Portilla J; Santibañez M
    BMC Cancer; 2018 Jan; 18(1):112. PubMed ID: 29382323
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence and genotype distribution of cervical human papillomavirus (HPV) among women in urban Tianjin, China.
    Chen X; Wallin KL; Duan M; Gharizadeh B; Zheng B; Qu P
    J Med Virol; 2015 Nov; 87(11):1966-72. PubMed ID: 26073652
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HPV Genotypes distribution in Indian women with and without cervical carcinoma: Implication for HPV vaccination program in Odisha, Eastern India.
    Senapati R; Nayak B; Kar SK; Dwibedi B
    BMC Infect Dis; 2017 Jan; 17(1):30. PubMed ID: 28056826
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-risk HPV prevalence and vaccination coverage among Indigenous women in the Colombian Amazon: Implications for cervical cancer prevention. Cross-sectional study.
    Sarmiento-Medina MI; de Amaya MP; Villamizar-Gómez L; González-Coba AC; Guzmán-Barajas L
    PLoS One; 2024; 19(2):e0297579. PubMed ID: 38315664
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidemiology of human papillomavirus infection in women from Xiamen, China, 2013 to 2023.
    Yao X; Li Q; Chen Y; Du Z; Huang Y; Zhou Y; Zhang J; Wang W; Zhang L; Xie J; Xu C; Ge Y; Zhou Y
    Front Public Health; 2024; 12():1332696. PubMed ID: 38590815
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions.
    Ducancelle A; Legrand MC; Pivert A; Veillon P; Le Guillou-Guillemette H; De Brux MA; Beby-Defaux A; Agius G; Hantz S; Alain S; Catala L; Descamps P; Postec E; Caly H; Charles-Pétillon F; Labrousse F; Lunel F; Payan C
    Arch Gynecol Obstet; 2014 Aug; 290(2):299-308. PubMed ID: 24622934
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human papillomavirus genotype spectrum in Czech women: correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles.
    Tachezy R; Hamsíková E; Hájek T; Mikysková I; Smahel M; Van Ranst M; Kanka J; Havránková A; Rob L; Guttner V; Slavík V; Anton M; Kratochvíl B; Kotrsová L; Vonka V
    J Med Virol; 1999 Aug; 58(4):378-86. PubMed ID: 10421405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.